However, whether this treatment strategy can achieve positive responses in PD-L1 expressing NSCLC or whether combination with platinum-based chemotherapy can achieve a better outcome in NSCLC patients has not been clarified. This evidence concerns the gene CD274 and non-small cell lung carcinoma.